Abdoulaye Karaboué

6PUBLICATIONS
24CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Medical robotics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 15, 2025
Timing of Immunotherapy in Practice: Feasibility and Impact of Morning Checkpoint Inhibitor Administration.

Pasquale F Innominato, Thierry Landré, Abdoulaye Karaboué

|Jun 04, 2024
Why does circadian timing of administration matter for immune checkpoint inhibitors' efficacy?

Abdoulaye Karaboué, Pasquale F Innominato, Nicholas I Wreglesworth

|Feb 25, 2022
Time-Dependent Efficacy of Checkpoint Inhibitor Nivolumab: Results from a Pilot Study in Patients with Metastatic Non-Small-Cell Lung Cancer.

Abdoulaye Karaboué, Thierry Collon, Ida Pavese

|Nov 27, 2016
Clinical Relevance of the First Domomedicine Platform Securing Multidrug Chronotherapy Delivery in Metastatic Cancer Patients at Home: The inCASA European Project.

Pasquale F Innominato, Sandra Komarzynski, Ali Mohammad-Djafari

Pageof 1

Frequent Collaborators

5 joint publications

Pasquale Innominato

5 joint publications

Francis Levi

1 joint publications

Sandra Komarzynski

1 joint publications

Ali Mohammad-Djafari